ALBANY — Curia announced Thursday that it would expand the pharmaceutical manufacturing capacity at its Rensselaer facility. The Albany-based contract R&
Tucson Weekly: Up The Creek (January 21 - January 27, 1999)
tucsonweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tucsonweekly.com Daily Mail and Mail on Sunday newspapers.
Curia CEO seized huge open door to biologics with back-to-back buyouts of LakePharma, Integrity Bio
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
Wave of acquisitions hits pharma industry this week
outsourcing-pharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outsourcing-pharma.com Daily Mail and Mail on Sunday newspapers.
Albany pharma company AMRI changes name to Curia, acquires California firm | The Daily Gazette
SECTIONS
ALBANY Albany Molecular Research Inc. announced Monday it had changed its name and announced Tuesday it had acquired a California biopharmaceutical firm.
AMRI is now Curia. Chairman and CEO John Ratliff said Monday that “Our new name reflects the assembled deep expertise of our people, the breadth of our products, services and solutions, and our relentless determination to help customers advance from curiosity to cure.”
Curia has entered a definitive agreement to acquire Integrity Bio, a formulation and fill-finish organization. Curia said Integrity’s biologic capabilities are complementary with Curia’s existing businesses. Terms of the deal were not disclosed; it is expected to close later this quarter.